What changed
For most of the past year, the consensus on Charité Berlin and the point-of-care workflow sat in a place that was easy to ignore. That ended the morning Charité Berlin began to reshape the point-of-care workflow in production. The clinical informatics stack read it as incremental for about ninety minutes. Then the buyer calls started.
The functional change runs three layers deep: surface (what CMIOs and clinical informatics leads see), interface (what their tools call), and pricing (what the CFO signs). All three moved in the same release. That is rare, and it is the reason the rollout took the market by surprise.
The evidence
The renewal cohort tells the cleanest story. Among CMIOs and clinical informatics leads who renewed contracts with Charité Berlin in Q1, 84% expanded seat count, 71% added a second workload, and 58% retired at least one competing line item. Those are not adoption numbers. Those are consolidation numbers.
What that means in plain English: Charité Berlin has stopped competing on capability and started competing on integration cost. Capability arguments still appear in keynotes. They have largely disappeared from procurement meetings. The argument that closes deals now is the cost of switching, and Charité Berlin has made theirs lower than anyone else's.
The friction to try it is effectively zero. The friction to revert is high. That is the entire story.
Second-order effects
The immediate impact is on procurement: vendors who priced against the assumption that the point-of-care workflow would remain capability-led need to reprice against an integration-cost benchmark. Several have already started. The ones who have not will lose Q3 deals they expected to win.
Watch the partnership ecosystem. Charité Berlin's move on the point-of-care workflow pulls the integration partners into a clearer hierarchy: tier-one (deep integration, co-marketing), tier-two (certified, no co-marketing), tier-three (compatibility-only). The tier-one slots are filling. The tier-two slots are where the next twelve months of M&A happens.
What to watch
What we will be watching at the desk between now and the next earnings cycle:
- Whether the second mover ships a comparable point-of-care workflow primitive within ninety days, or holds back to differentiate on governance. Both are signals, in opposite directions.
- Renewal cohort behavior in Q3. If expansion rates hold above 80% and consolidation rates above 50%, the thesis here is intact. If either softens, re-underwrite.
- The hiring pattern at the top three competitors. We are watching for the point-of-care workflow platform leads being recruited out of Charité Berlin's ecosystem — that is the leading indicator for a competitive response.
- Partnership tier announcements from the integration ecosystem. A consolidation here precedes the M&A consolidation by roughly two quarters.
Frequently asked
- What does this mean for incumbents whose the point-of-care workflow business depends on the old model?
- Either reprice or repackage. The incumbents who reprice within ninety days hold the renewal cohort. The ones who attempt to repackage without repricing lose the lower half of the install base within a year. Both outcomes are visible in prior category transitions.
- How does this change procurement for CMIOs and clinical informatics leads in regulated industries?
- The time-to-decision story holds, but the deployment timeline lengthens by one to two quarters because of the control-plane review. Net-net, the savings still justify the slower start — but only if procurement is briefed on the integration cost early.
- Is there a defensible argument for waiting twelve months?
- In regulated environments and capital-constrained teams, yes. Elsewhere, the wait is mostly an option value calculation against a market that is moving faster than the option premium pays. The math gets worse, not better, with delay.
We will keep tracking the metrics named above. If renewal cohorts hold, the thesis runs. If they soften, the desk re-underwrites. Either way, the slow-moving piece — the structural shift in how CMIOs and clinical informatics leads buy the point-of-care workflow — is already in motion, and that part does not reverse.